Home / News
-
-
Roche announced that it has expanded its partnership with the US Centers for Disease Control and Prevention to improve HIV and tuberculosis prevention, testing, and treatment.2023-03-01View More
-
-
On February 24, China National Medical Device Co., Ltd. and GE Healthcare China signed an agreement in Beijing to establish a medical equipment joint venture in China to meet the growing demand of China's medical and health market.2023-02-28View More
-
-
The $3.95 billion worldwide molecular diagnostic POC testing market is seeing increasing international activity with China becoming a particularly intriguing part of the Asia Pacific region according to The Market and Future Potential for Molecular Point of Care, published by Kalorama Information.2023-02-28View More
-
-
CareDx reported after the close of the market on Monday year-over-year revenue gains of 4 percent for the fourth quarter of 2022 and 9 percent for the full year.2023-02-28View More
-
-
POCT is a clinical test that is performed next to the patient and sampled on-site for immediate analysis. Simplicity and convenience are always the most important features of POCT.2023-02-27View More
-
-
The US Food and Drug Administration said on Friday evening that it has issued an Emergency Use Authorization for Lucira Health's Lucira COVID-19 & Flu test, the first over-the-counter, at-home diagnostic test that can differentiate and detect influenza A and B, as well as SARS-CoV-2.2023-02-27View More
-
-
Chembio Diagnostics has obtained a CLIA waiver from the US Food and Drug Administration for its DPP HIV-Syphilis System, the firm announced on Friday.2023-02-27View More
-
-
On February 22, the National Development and Reform Commission announced the list of the 29th of newly identified and all national enterprise technology centers. More than 20 IVD-related enterprises are on the list!2023-02-24View More
-
-
The US Food and Drug Administration on Wednesday granted Emergency Use Authorization for Mologic's over-the-counter SARS-CoV-2 antigen test.2023-02-24View More
-
-
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, reported financial results for the quarter and full year ended December 31, 2022.2023-02-24View More
-
-
On February 20, Roche Group and Zhuhai People's Hospital Medical Group formally signed a strategic cooperation agreement.2023-02-23View More
-
-
Spectrum Solutions announced the U.S. Food and Drug Administration (FDA) has granted 510(k) Class II clearance to the SDNA Saliva Collection Device as a microbial nucleic acid storage and stabilization device.2023-02-23View More
-
-
Veracyte, Inc. (Nasdaq: VCYT) announced financial results for the fourth quarter and full year ended December 31, 2022.2023-02-23View More
-
-
On 18 February, a launch ceremony was held in Macau for Macau Biotech Company jointly established by Namyue Group and Shenzhen Yhlo Biotech Co., Ltd.2023-02-22View More
-
-
Sherlock Biosciences said that the U.S. Patent and Trademark Office (USPTO) has granted a patent for the diagnostic use of the Cas12 enzyme, an integral part of the firm's diagnostic testing technology.2023-02-22View More
-
-
Becton Dickinson announced that its BD Onclarity human papillomavirus virus test has been approved by the US Food and Drug Administration for use with the Hologic ThinPrep Pap test.2023-02-22View More
-
-
On February 19, 2023, Abbott, a leading medical and health company in the world, signed a strategic cooperation memorandum with China Medical Devices Co., Ltd., a highly specialized medical device industry chain platform in China, which is affiliated to Sinopharm Holdings.2023-02-21View More
-
-
Global talent leader WilsonHCG has published its annual Fortune 100 Employment Branding Report.2023-02-21View More
-
-
OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced its financial results for the three months ended December 31, 2022.2023-02-21View More
-
-
After issuing emergency use authorizations for more than 400 COVID-19 tests, the U.S. Food and Drug Administration said Wednesday that it is ending its EUA review of new in vitro diagnostics.2023-02-20View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.